arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

CVRx, Inc.

CVRX
$2.71 ▼ -0.17 (-5.90%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
7 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
16
Health
Poor
Bearish
auto_awesome

Analytical Summary

CVRx, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $70.7M
Dividend Yield —
Revenue Growth 10.4% ↘
Op. Margin -90.5% ↗
ROIC -57.7% ↘
FCF / Share $-1.56 ↗
Trailing P/E —
Price / Book 1.8x
FCF Yield —
Debt / Equity 1.26
info Valuation on last close. End-of-day price, Sep 23, 2026.

7-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$56.65M
↑ +10.4% —
Net Income Profit after all expenses
$-53.31M
↑ +11.1% —
Operating Margin Operating profit as % of sales
-90.5%
↑ +22.0% 3th
FCF / Share Free cash flow per share
$-1.56
↑ +12.8% —
Long-Term Debt Long-term obligations
$49.51M
— +0.5% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)
  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑
3
Returns ↓
6
Financial Health ↑
26
Cash Quality ↑
52

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 7 years · 27 quarters